@alzinova.com
Alzinova AB operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Alzinova AB is a Swedish clinical-stage biopharma company that is at the forefront of developing an active immunotherapy to combat Alzheimer's disease. With over 30 million individuals diagnosed with Alzheimer's worldwide, the need for a breakthrough treatment is more pressing than ever. Alzinova is working tirelessly to address this unmet medical need by utilizing their unique proprietary AβCC Peptide™ Technology to develop disease-modifying treatments for Alzheimer's.
Their vaccine is currently in clinical development and undergoing testing in patients. Alzheimer's disease is a devastating condition that affects not only the patients but also their families and society as a whole. It imposes a high cost on society and is currently the only top killer that cannot be prevented, cured, or slowed down.
Alzinova is determined to change this narrative by pioneering the development of a vaccine that has the potential to revolutionize the treatment of Alzheimer's. Investors interested in supporting this groundbreaking work can find more information on Alzinova's website, including financial reports, press releases, and details about the company's shares listed on Nasdaq First North Growth Market, Stockholm. Join Alzinova in their mission to make a difference in the lives of Alzheimer's patients and their families
Company Type
Public Company
Company Size
2-10
Year Founded
2011
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online